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Key Clinical Message
In case of a cerebral abscess without known cause, Pulmonary arteriovenous
malformations (PAVM) screening should be performed. If PAVM(s) is identi-
fied, Hereditary hemorrhagic telangiectasia (HHT) is very likely and should
always be considered. This case shows the benefit of familial screening for HHT
and PAVM.
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Background
Hereditary hemorrhagic telangiectasia (HHT), also
known as Osler-Weber-Rendu disease, is an autosomal
dominant hereditary disorder characterized by a variety
of clinical manifestations due to the presence of multiple
mucocutaneous telangiectases and arteriovenous malfor-
mations (AVMs) in internal organs, most commonly
lungs, liver, and cerebrum. The most frequent clinical
manifestation is spontaneous and recurrent epistaxis,
affecting more than 95% of all HHT patients. Pulmonary
arteriovenous malformations (PAVMs) are observed in
about one-third of all HHT patients [1] and can cause
cerebral abscess or stroke due to paradoxical embolism
[1, 2]. The prevalence of cerebral abscess among HHT
patients with PAVM is reported to be 7.8% [3], which is
nearly 400 times the rate seen in the general population
[4]. Thus, HHT patients should be screened for PAVMs,
and patients with PAVMs are recommended treatment
by embolization, whenever possible [5, 6]. Cerebral
AVMs are present in at least 10% of HHT patients
and hepatic AVMs are common, but rarely symptomatic
[7, 8].
In Denmark, the reported prevalence is approximately
1/6500 [9], roughly comparable to that of other Euro-
pean, U.S., and Japanese populations.
Genetically HHT is a heterogeneous disorder caused by
mutations in at least three known genes: Endoglin (ENG),
activin A receptor type II-like 1 (ACVRL1), and SMA-
and MAD-related protein 4 (SMAD4). HHT1 is caused
by mutations in ENG (OMIM 131195 [Online Mendelian
Inheritance in Man, http://www.omim.org/entry/131195?
search=eng&highlight=eng]) and HHT2 by mutations in
ACVRL1 (OMIM 601284 [Online Mendelian Inheritance
in Man, http://www.omim.org/entry/601284?search=acvr
l1&highlight=acvrl1]). A phenotype consisting of HHT
and juvenile polyposis syndrome is caused by mutations
in the SMAD4 gene (OMIM 600993 [Online Mendelian
Inheritance in Man, http://www.omim.org/entry/600993?
search=smad4&highlight=smad4]).
Hereditary hemorrhagic telangiectasia is a clinical diag-
nosis, according to the Curacao criteria [10]. In
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approximately 85% of the HHT patients, a mutation in
either ENG or ACVRL1 [11] can be identified at mutation
analysis. Only around 2% of HHT patients have muta-
tions in SMAD4 [12, 13].
Despite identification of the genes causing HHT, the
mechanisms for the pathogenesis of HHT and for the
development of telangiectases and AVMs remain obscure.
Case Presentation
A 16-year-old patient (III-1, Fig. 1) was referred to the
national HHT Center, Odense University Hospital for
embolization of a large PAVM, which was detected by
chance after a traffic accident (case story published in Dan-
ish [14]). He had a history of spontaneous epistaxis once a
month. CT of Thorax showed two PAVMs localized in the
right lung, which were embolized, increasing the SaO2
from 88% to 98% and the PaO2 from 7.5–13.3 kPa.
Sequencing of ENG identified a mutation (c.1483delC,
p.Leu495Trpfs*23 (NM_001114753.2)) in the coding
region of exon 11. The frameshift mutation was not pre-
viously reported but considered pathogenic as it inserts a
premature stop codon.
This index patient (proband) had a family history of
cerebral abscesses.
The father of the proband (II-1, Fig. 1) had daily epis-
taxis lasting 2–4 min, and cerebral abscess at the age of
39, which lead to a three-month-long hospitalization and
cerebral abscess sequelae, including a minor visual field
defect and fatigue. Typical telangiectases were detected in
the nasal and oral cavity and on the facial skin. CT thorax
revealed a PAVM, which was embolized. He was analyzed
for the ENG mutation previously identified in the son
and carried this mutation.
The paternal aunt (II-4, Fig. 1) had a cerebral abscess
at the age of 31 years, which lead to 2 months absent
from work and long-term sequela, including fatigue. She
had epistaxis on a daily basis, blue and clubbed nails,
cyanotic lips, progressive dyspnea and telangiectases in
the nasal cavity, on the lips and tongue. CT thorax
revealed two large PAVMs situated bilaterally, which were
embolized. She was also analyzed for the familial ENG
mutation and was a carrier.
Two of the cousins (III-3 and III-4, Fig. 1) both carried
the familial ENG mutation. III-4 had epistaxis, typical
telangiectases in the nasal mucosa, and three small
PAVMs identified by CT thorax. One PAVM was embo-
lized, and the other two were too small to undergo
embolization. III-3 did not, at the age of 19 years, have
any symptoms of HHT, and transthoracic contrast
echocardiography was normal, revealing no indication of
a PAVM. Cerebral MRI, which was performed as he also
had epilepsy, showed a cavernous hemangioma. III-3 and
III-4 both carried the familial ENG mutation.
The brother of the proband (III-2, Fig. 1), the paternal
uncle (II-5, Fig. 1), and a cousin (III-9, Fig. 1) did not
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Figure 1. Pedigree of the family. Arrow marks the proband; +, mutation positive; and , mutation negative. Age is indicated for all tested family
members.
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carry the familial mutation. None of them showed clinical
signs of HHT.
Outcome and Follow-up
All at-risk family members were offered genetic testing
for the familial ENG mutation, and subsequently clinical
evaluation of HHT manifestations with PAVM screening
and embolization, when relevant.
Discussion
Cerebral abscess is a serious condition and is fatal in 10%
of the cases [15]. PAVMs, associated with HHT, are
known to cause cerebral abscesses. We present a rare fam-
ily with two cases of cerebral abscesses occurring in first-
degree relatives.
In this family, the PAVMs and the secondary diagnosis
of HHT were not realized until our proband was involved
in a traffic accident and accidentally diagnosed with
PAVM and successively HHT. Afterward, his family
underwent genetic testing and PAVM screening, in which
it was realized that his father and paternal aunt both had
experienced a cerebral abscess secondary to PAVMs. Both
survived the potential fatal cerebral abscess; nevertheless,
they both experienced some sequelae. In the rest of the
family, additional PAVMs was diagnosed in two family
members, possibly preventing further cases of cerebral
abscesses – or strokes.
The prevalence of cerebral abscess among HHT patients
with PAVM is reported to be 7.8%, which is nearly 400
times the rate seen in the general population [3, 4]. In
patients with cerebral abscess without known cause,
PAVM screening should be performed, and in case of
identified PAVM(s), HHT is the most likely diagnosis
and should always be considered [16].
Surveillance in HHT families includes PAVM screening,
with the intention to embolize these to prevent cerebral
complications, to raise the oxygenation, and to prevent
rupture of the PAVMs [8]. Genetic counseling should be
offered to HHT patients and first-degree relatives to HHT
patients in order to ensure HHT and PAVM screening of
relevant family members.
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